We report on the
synthesis and characterization of novel mesoporous
chiral polyboronates obtained by condensation of (
R
,
S
)/(
S
,
S
)-hexane-1,2,5,6-tetrol
(HT) with simple aromatic diboronic acids (e.g., 1,3-benzenediboronic
acid) (BDB). HT is a cellulose-derived building block comprising two
1,2-diol structures linked by a flexible ethane bridge. It typically
consists of two diastereomers one of which [(
S
,
R
)-HT] can be made chirally pure. Boronic acids are abundantly
available due to their importance in Suzuki–Miyaura coupling
reactions. They are generally considered nontoxic and easy to synthesize.
Reactive dissolution of generally sparingly soluble HT with BDB, in
only a small amount of solvent, yields the mesoporous HT/polyboronate
materials by spontaneous precipitation from the reaction mixture.
The 3D nature of HT/polyboronate materials results from the entanglement
of individual 1D polymeric chains. The obtained BET surface areas
(SAs) and pore volumes (PVs) depend strongly on HT’s diastereomeric
excess and the meta/para orientation of the boronic acids on the phenyl
ring. This suggests a strong influence of the curvature(s) of the
1D polymeric chains on the final materials’ properties. Maximum
SA and PV values are respectively 90 m
2
g
–1
and 0.44 mL g
–1
. Variably sized mesopores, spanning
mainly the 5–50 nm range, are evidenced. The obtained pore
volumes rival the ones of some covalent organic frameworks (COFs),
yet they are obtained in a less expensive and more benign fashion.
Moreover, currently no COFs have been reported with pore diameters
in excess of 5 nm. In addition, chiral boron-based COFs have presently
not been reported. Scanning electron microscopy reveals the presence
of micrometer-sized particles, consisting of aggregates of plates,
forming channels and cell-like structures. X-ray diffraction shows
the crystalline nature of the material, which depends on the nature
of the aromatic diboronic acids and, in the specific case of 1,4-benzenediboronic
acid, also on the applied diastereomeric excess in HT.
We have investigated the synthesis
of hexane-1,2,5,6-tetrol (hereafter
“tetrol”) from aqueous solutions of biomass-derived
levoglucosanol (hereafter “Lgol”) using a (10 wt %)Pt-(10
wt %)WO
x
/TiO2 catalyst in both
batch and continuous flow reactors. The tetrol selectivity was over
90% with Lgol feed concentrations of 10–30 wt %. Most of the
Lgol feed stereochemistry was preserved (notably 91%), with threo-Lgol
(hereafter “t-Lgol”) and erythro-Lgol (hereafter “e-Lgol”)
converting to (S,S)-tetrol and (S,R)-tetrol, respectively. The rate of
Lgol conversion was found to be first-order in the Lgol concentration,
suggesting that the catalyst surface is not saturated with Lgol. The
measured reaction order for H2 was zero, which is consistent
with either a mechanism involving acid-catalyzed irreversible C–O
bond cleavage of Lgol followed by metal-catalyzed hydrogenation of
reactive intermediates or one where all of the metal sites are saturated
with H2. When the reaction was run in a continuous flow
reactor, the catalyst exhibited deactivation with increasing time-on-stream
but was found partially regenerable with a consecutive calcination
and reduction treatment. Deactivation was concluded to be caused mainly
by carbon deposition, with some W-leaching from the catalyst in the
initial stages of reaction. The here demonstrated understanding of
reaction kinetics and catalyst stability could facilitate the development
of improved processes to produce hexane-1,2,5,6-tetrol from biomass.
In this work, we explore the catalytic upgrading of ethanol into diesel following an approach based on the initial Guerbet coupling of ethanol followed by etherification. The results presented are...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.